Characterization of the adipose tissue atrophy induced by peroxisome proliferators in mice.
In the present study, we characterized the effects of peroxisome proliferators (PP) on adipose tissue in mice. Treatment with potent PP, such as perfluorooctanoic acid (PFOA), 2-methyl-2-(p(1,2,3,4-tetrahydroxy-naphthyl)-phenoxy)propionic acid, (4-chloro-6-(2,3-xylidino)2-pyrimidinylthio) acetic acid, and di(2-ethylhexyl)phthalate, caused dramatic decreases in adipose tissue weight, whereas the moderately potent PP, acetylsalicylic acid, had a relatively weak effect. This decrease in weight reflects a loss of fat from adipocytes rather than a loss of cells, as demonstrated by constant DNA content. The dose-dependency and time-course experiments indicate that peroxisome proliferation occurs simultaneously with or prior to adipose tissue atrophy. Thus, hepatic peroxisome proliferation might result in the increased mobilization of lipids and lipid utilization in liver. The enhanced adipose tissue hormone-sensitive lipase (HSL) activity and down-regulated lipoprotein lipase (LPL) activity observed upon PP treatment might, at least in part, explain the loss of fat via increased FA release from adipocytes and/or decreased FA uptake from the circulation, respectively. In addition, the possible involvement of the increased tumor necrosis factor alpha expression found upon PFOA treatment in reducing the insulin sensitivity of adipose tissue and thereby altering LPL and HSL activities is discussed.
Xie
Yi
Y
Unit for Biochemical Toxicology, Department of Biochemistry and Biophysics, Stockholm University, Sweden. yi@dbb.su.se
Yang
Qian
Q
Nelson
B Dean
BD
DePierre
Joseph W
JW
D000273:Adipose Tissue / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D000818:Animals; D015153:Blotting, Western; D004591:Electrophoresis, Polyacrylamide Gel; D008066:Lipolysis; D008071:Lipoprotein Lipase / Q000378:metabolism; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009929:Organ Size / Q000187:drug effects; D020025:Peroxisome Proliferators / Q000494:pharmacology*; D002787:Sterol Esterase / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D020025:Peroxisome Proliferators; D014409:Tumor Necrosis Factor-alpha; D002787:Sterol Esterase; D008071:Lipoprotein Lipase